APA (7th ed.) Citation

Li, H., Wang, J., Zhang, G., Kuang, D., Li, Y., He, X., . . . Duan, X. (2023). Transarterial chemoembolization combined donafenib with/without PD-1 for unresectable HCC in a multicenter retrospective study. Frontiers in Immunology, 14, . https://doi.org/10.3389/fimmu.2023.1277329

Chicago Style (17th ed.) Citation

Li, Hao, et al. "Transarterial Chemoembolization Combined Donafenib With/without PD-1 for Unresectable HCC in a Multicenter Retrospective Study." Frontiers in Immunology 14 (2023). https://doi.org/10.3389/fimmu.2023.1277329.

MLA (9th ed.) Citation

Li, Hao, et al. "Transarterial Chemoembolization Combined Donafenib With/without PD-1 for Unresectable HCC in a Multicenter Retrospective Study." Frontiers in Immunology, vol. 14, 2023, https://doi.org/10.3389/fimmu.2023.1277329.